ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Miami, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis
Dermatitis
Skin Diseases
Immune System Diseases
Pruritus
Eczematous Skin Diseases
Food Hypersensitivity

Eczema trials near Miami, FL, USA:

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have ...

Enrolling
Eczema, Atopic
Atopic Dermatitis
Drug: PF-08049820
Drug: Placebo

Phase 2

Pfizer
Pfizer

Miami, Florida, United States of America and 22 other locations

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

Enrolling
Eczema Atopic Dermatitis
Eczema, Atopic
Drug: Camoteskimab
Drug: Placebo

Phase 2

Apollo Therapeutics

Miami, Florida, United States and 84 other locations

This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis.

Active, not recruiting
Atoptic Dermatitis
Drug: EVO756
Drug: Placebo control

Phase 2

Evommune

Coral Gables, Florida, United States of America and 26 other locations

This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...

Active, not recruiting
Atopic Dermatitis
Drug: Placebo
Drug: ADX-914

Phase 2

Q32 Bio

Miami, Florida, United States and 27 other locations

The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 2...

Active, not recruiting
Atopic Dermatitis
Drug: Vehicle Cream
Drug: Tapinarof cream, 1%

Phase 3

Organon
Organon

Boca Raton, Florida, United States of America and 47 other locations

The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...

Active, not recruiting
Atopic Dermatitis
Drug: Lebrikizumab

Phase 4

Lilly
Lilly

Miami, Florida, United States and 71 other locations

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Active, not recruiting
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo

Phase 2

Bluefin Biomedicine, Inc.

Coral Gables, Florida, United States and 88 other locations

The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...

Active, not recruiting
Atopic Dermatitis
Drug: Dupilumab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Coral Gables, Florida, United States and 83 other locations

This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.

Active, not recruiting
Eczema
Atopic Dermatitis
Drug: ATI-045
Drug: Placebo

Phase 2

Aclaris Therapeutics
Aclaris Therapeutics

Coral Gables, Florida, United States and 60 other locations

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis

Active, not recruiting
Atopic Dermatitis
Biological: Barzolvolimab
Drug: Matching placebo

Phase 2

Celldex Therapeutics
Celldex Therapeutics

South Miami, Florida, United States and 36 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems